Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women
- PMID: 18506546
- PMCID: PMC2518007
- DOI: 10.1007/s11606-008-0633-x
Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women
Abstract
Background: Human papillomavirus (HPV) testing is increasingly being used to determine the optimal cervical cancer screening interval in older women. Little is known about women's attitudes toward HPV testing or how these attitudes may influence medical discussions about cervical cancer screening.
Methods: Preferences for HPV and concomitant Papanicolaou (Pap) testing were assessed through in-person interviews with diverse women aged 50 to 80 years recruited from community and university-based practices.
Results: Eight hundred and sixty-five women (257 White, 87 African American, 149 Latina, and 372 Asian) were interviewed. Approximately 60% of participants wanted to be tested for HPV and another 15% would undergo testing if recommended by their physician. Among those wanting HPV testing, 94% would want more frequent than annual Pap tests if they had a positive HPV test and a normal Pap test. Two thirds of those under age 65 would be willing to switch to triennial Pap testing, and half of those aged 65 and older would be willing to discontinue Pap testing, if they had a negative HPV test and normal Pap test. Preferences for testing varied by ethnicity, age, place of birth, and cancer history.
Conclusions: The majority of older women were willing to use HPV testing to make decisions about frequency and duration of cervical cancer screening, but up to one third would want at least annual, ongoing screening regardless of HPV test results. Efforts should be made to ensure that HPV testing is used to reinforce appropriate utilization of screening tests.
Figures
Similar articles
-
Recent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testing.Prev Med. 2020 Jan;130:105928. doi: 10.1016/j.ypmed.2019.105928. Epub 2019 Nov 19. Prev Med. 2020. PMID: 31756351
-
Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.Arch Pathol Lab Med. 2012 Dec;136(12):1533-40. doi: 10.5858/arpa.2011-0609-OA. Epub 2012 Aug 20. Arch Pathol Lab Med. 2012. PMID: 22900617
-
The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.Cancer Prev Res (Phila). 2021 Jan;14(1):105-112. doi: 10.1158/1940-6207.CAPR-20-0280. Epub 2020 Sep 11. Cancer Prev Res (Phila). 2021. PMID: 32917643
-
[Prevention of cervical cancer: screening, progress and perspectives].Presse Med. 2007 Jan;36(1 Pt 2):92-111. doi: 10.1016/j.lpm.2006.10.023. Epub 2006 Dec 11. Presse Med. 2007. PMID: 17296477 Review. French.
-
Cost-effectiveness of primarily human papillomavirus-based cervical cancer screening in settings with currently established Pap screening: a systematic review commissioned by the German Federal Ministry of Health.Int J Technol Assess Health Care. 2008 Spring;24(2):184-92. doi: 10.1017/S0266462308080264. Int J Technol Assess Health Care. 2008. PMID: 18400122 Review.
Cited by
-
Short-term clinical and immunologic effects of poly-gamma-glutamic acid (γ-PGA) in women with cervical intraepithelial neoplasia 1 (CIN 1): A multicenter, randomized, double blind, phase II trial.PLoS One. 2019 Jun 20;14(6):e0217745. doi: 10.1371/journal.pone.0217745. eCollection 2019. PLoS One. 2019. PMID: 31220105 Free PMC article. Clinical Trial.
-
Acceptable and Preferred Cervical Cancer Screening Intervals Among U.S. Women.Am J Prev Med. 2015 Dec;49(6):e99-107. doi: 10.1016/j.amepre.2015.04.025. Epub 2015 Jul 2. Am J Prev Med. 2015. PMID: 26141914 Free PMC article.
-
Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.Obstet Gynecol. 2015 Feb;125(2):317-329. doi: 10.1097/AOG.0000000000000638. Obstet Gynecol. 2015. PMID: 25568994 Free PMC article.
-
Women's intentions to receive cervical cancer screening with primary human papillomavirus testing.Int J Cancer. 2013 Dec 15;133(12):2934-43. doi: 10.1002/ijc.28324. Epub 2013 Jul 16. Int J Cancer. 2013. PMID: 23754203 Free PMC article.
-
Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists.Am J Obstet Gynecol. 2013 Feb;208(2):109.e1-7. doi: 10.1016/j.ajog.2012.11.015. Epub 2012 Nov 22. Am J Obstet Gynecol. 2013. PMID: 23159688 Free PMC article.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.297.8.813', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.297.8.813'}, {'type': 'PubMed', 'value': '17327523', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17327523/'}]}
- Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813–9. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1086/505982', 'is_inner': False, 'url': 'https://doi.org/10.1086/505982'}, {'type': 'PubMed', 'value': '16886157', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16886157/'}]}
- Dunne EF, Markowitz LE. Genital human papillomavirus infection. Clin Infect Dis. 2006;43(5):624–9. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1769629', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1769629/'}, {'type': 'PubMed', 'value': '11919208', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11919208/'}]}
- Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244–65. - PMC - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '16880312', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16880312/'}]}
- Irwin K, Montano D, Kasprzyk D, Carlin L, Freeman C, Barnes R, et al. Cervical cancer screening, abnormal cytology management, and counseling practices in the United States. Obstet Gynecol. 2006;108(2):397–409. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12469763', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12469763/'}]}
- Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52(6):342–62. - PubMed
